Jaguar Health Stock Surges On FDA Breakthrough Discussions For Rare Disease Therapy

Jaguar Health Inc (NASDAQ:JAGX) shares are climbing Wednesday morning. The momentum follows the company's announcement of preliminary discussions with the FDA to evaluate a Breakthrough Therapy Designation for oral liquid crofelemer.
Open original source